ChinaSouthernPowerGridTechnology(688248)
Search documents
南网科技:询价转让价格为42.89元/股
Mei Ri Jing Ji Xin Wen· 2026-01-12 07:41
每经AI快讯,1月12日,南网科技(688248.SH)公告称,根据2026年1月12日询价申购情况,初步确定的 本次询价转让价格为42.89元/股。参与报价的机构投资者家数为64家,有效认购股份数量为43,398,000 股,对应转让底价的有效认购倍数为5.12倍。本次询价转让拟转让股份已获全额认购,初步确定受让方 为20家机构投资者,拟受让股份总数为8,470,500股。此次转让不涉及公司控制权变更,不会影响公司治 理结构和持续经营。 ...
南方电网电力科技股份有限公司 股东询价转让计划书
Xin Lang Cai Jing· 2026-01-09 23:52
登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码:688248 证券简称:南网科技公告编号:2026-001 股东南网能创股权投资基金(广州)合伙企业(有限合伙)(以下简称"出让方")保证向南方电网电力 科技股份有限公司(以下简称"南网科技"或"公司")提供的信息内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其真实性、准确性和完整性依法承担法律责任。 本公司董事会及全体董事保证公告内容与信息披露义务人提供的信息一致。 重要内容提示: ● 本次询价转让的受让方为具备相应定价能力和风险承受能力的机构投资者。 一、拟参与转让的股东情况 (一)出让方的名称、持股数量、持股比例 出让方委托中信证券股份有限公司(以下简称"中信证券")组织实施本次询价转让。截至2026年1月9 日,出让方所持首发前股份的数量、占公司总股本比例情况如下: (二)关于出让方是否为公司控股股东、实际控制人、持股5%以上的股东、董事、高级管理人员 本次询价转让的出让方南网能创股权投资基金(广州)合伙企业(有限合伙)为南网科技持股5%以上 的股东,非南网科技的控股股东、实际控制人、董事、高级管理人员。 (三)出让方关于拟转让股份权 ...
南方电网电力科技股份有限公司股东询价转让计划书
Shang Hai Zheng Quan Bao· 2026-01-09 21:42
登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码:688248 证券简称:南网科技 公告编号:2026-001 南方电网电力科技股份有限公司股东询价转让计划书 ● 本次询价转让不通过集中竞价交易或大宗交易方式进行,不属于通过二级市场减持。受让方通过询价 转让受让的股份,在受让后6个月内不得转让; ● 本次询价转让的受让方为具备相应定价能力和风险承受能力的机构投资者。 一、拟参与转让的股东情况 (一)出让方的名称、持股数量、持股比例 出让方委托中信证券股份有限公司(以下简称"中信证券")组织实施本次询价转让。截至2026年1月9 日,出让方所持首发前股份的数量、占公司总股本比例情况如下: ■ (二)关于出让方是否为公司控股股东、实际控制人、持股5%以上的股东、董事、高级管理人员 股东南网能创股权投资基金(广州)合伙企业(有限合伙)(以下简称"出让方")保证向南方电网电力 科技股份有限公司(以下简称"南网科技"或"公司")提供的信息内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其真实性、准确性和完整性依法承担法律责任。 本公司董事会及全体董事保证公告内容与信息披露义务人提供的信息一致。 重要内容 ...
南网科技(688248.SH):股东拟询价转让1.5%股份
Ge Long Hui A P P· 2026-01-09 14:05
Core Viewpoint - Nanfang Technology (688248.SH) plans to participate in the pre-IPO share transfer inquiry, with the selling shareholder being Nanfang Energy Creation Equity Investment Fund (Guangzhou) Partnership (Limited Partnership) [1] Group 1 - The total number of shares to be transferred is 8,470,500 shares, which represents 1.50% of Nanfang Technology's total share capital [1]
1月9日晚间重要公告一览
Xi Niu Cai Jing· 2026-01-09 10:19
Group 1 - China Shipbuilding Defense expects a net profit of 940 million to 1.12 billion yuan for 2025, an increase of 149.61% to 196.88% year-on-year [1] - China First Heavy Industries has only undertaken a small number of related accessory projects and has not generated revenue from them [2] - Huanyu Electronics plans to invest 30 million yuan in a private equity fund focused on AI and emerging industries [3] Group 2 - Zhixiang Jintai's GR1803 injection has been included in the priority review list by the National Medical Products Administration [4] - JianKai Technology's shareholder plans to reduce holdings by up to 3% of the company's shares [5] - Debon Holdings will continue to suspend trading from January 12 due to significant matters being planned [6] Group 3 - South Network Technology's shareholder intends to transfer 847.05 million shares, accounting for 1.50% of the total share capital [7] - Hengrui Medicine has received approval for clinical trials of four drugs [8] - Daotong Technology expects a net profit of 900 million to 930 million yuan for 2025, a year-on-year increase of 40.42% to 45.10% [10] Group 4 - Betta Pharmaceuticals has invested 50 million yuan to acquire a 20% stake in Hangzhou Zhixing Pharmaceutical [11] - Tianyu Biology reported a 10.38% year-on-year decline in cumulative sales revenue for 2025 [12] - Lifang Pharmaceutical's subsidiary has obtained a drug registration certificate for a pain relief product [13] Group 5 - R&F Properties reported a total sales revenue of approximately 14.21 billion yuan for 2025 [14] - Wanfu Biology expects a net profit decline of 87.71% to 91.81% for 2025 [15] - Dazhi expects a negative net profit for 2025 [16] Group 6 - Dongzhu Ecology is negotiating to terminate the acquisition of control over a satellite communication company [17] - Baotai has received a milestone payment of 10 million USD from Hikma Pharmaceuticals [18] - Huace Navigation expects a net profit of 670 million to 690 million yuan for 2025, a year-on-year increase of 14.84% to 18.27% [19] Group 7 - Shenzhen Gas reported a net profit decline of 3.45% for 2025 [20] - Baogang Co. plans to adjust the price of rare earth concentrate for Q1 2026 to 26,834 yuan per ton [21] - Jiuding Investment expects to report a loss for 2025 [22] Group 8 - Shanghai Pharmaceuticals has received a drug registration certificate for a treatment for myasthenia gravis [23] - Hualan Biological plans to acquire a 35% stake in Guangfeng Capsule [24] - Ruina Intelligent plans to invest 169.9 million yuan in a new R&D production base for heat pumps [25] Group 9 - Wantong Development expects to report a loss for 2025 [26] - Xianghe Industrial has completed the purchase of a 5% stake in Hezhixiang Technology [27] - Guangkang Biochemical received a warning letter from the Guangdong Securities Regulatory Commission [28] Group 10 - Xiaoming Co. reported a 37.07% year-on-year decline in chicken product sales revenue for December 2025 [29] - Luokai Co. won a procurement project from State Grid Fujian Power worth approximately 48.2 million yuan [30] - Minhe Co. reported a 65.22% year-on-year increase in the sales of commodity chick seedlings for December 2025 [31] Group 11 - Zhenghai Biological has obtained a registration certificate for calcium silicate bio-ceramic materials [32] - Three Gorges Energy reported a 5.99% year-on-year increase in cumulative total power generation for 2025 [33] - Huisheng Biological expects a net profit of 235 million to 271 million yuan for 2025 [34] Group 12 - Maihe Co. announced the release of the detention measures against its chairman [35] - Wandong's Alzheimer's project has been included in a national major special project for innovative drug development [36] - Kangxin New Materials plans to transfer forest land assets with a book value of 1.203 billion yuan [37] Group 13 - Greenland Holdings expects a net loss of 16 billion to 19 billion yuan for 2025 [39] - Zhongxin Fluorine Materials has obtained a pesticide production license [40]
南网科技(688248.SH)股东拟询价转让1.5%公司股份
智通财经网· 2026-01-09 10:02
智通财经APP讯,南网科技(688248.SH)披露股东询价转让计划书,拟参与本次询价转让的股东为南网 能创股权投资基金(广州)合伙企业(有限合伙),拟转让股份的总数为847.05万股,占公司总股本的比例 为1.5%。 ...
南网科技(688248) - 南网科技:股东询价转让计划书
2026-01-09 09:32
证券代码:688248 证券简称:南网科技 公告编号:2026-001 南方电网电力科技股份有限公司 股东询价转让计划书 股东南网能创股权投资基金(广州)合伙企业(有限合伙)(以下简称"出 让方")保证向南方电网电力科技股份有限公司(以下简称"南网科技"或"公 司")提供的信息内容不存在任何虚假记载、误导性陈述或者重大遗漏,并对其 真实性、准确性和完整性依法承担法律责任。 本公司董事会及全体董事保证公告内容与信息披露义务人提供的信息一致。 重要内容提示: 拟参与南网科技首发前股东询价转让(以下简称"本次询价转让")的股 东为南网能创股权投资基金(广州)合伙企业(有限合伙); 出让方拟转让股份的总数为 8,470,500 股,占南网科技总股本的比例为 1.50%; 本次询价转让不通过集中竞价交易或大宗交易方式进行,不属于通过二级 市场减持。受让方通过询价转让受让的股份,在受让后 6 个月内不得转让; 本次询价转让的受让方为具备相应定价能力和风险承受能力的机构投资 者。 一、拟参与转让的股东情况 (一)出让方的名称、持股数量、持股比例 出让方委托中信证券股份有限公司(以下简称"中信证券")组织实施本次 询价转让。 ...
南网科技(688248) - 中信证券股份有限公司关于南方电网电力科技股份有限公司股东向特定机构投资者询价转让股份相关资格的核查意见
2026-01-09 09:31
中信证券股份有限公司 关于南方电网电力科技股份有限公司股东 向特定机构投资者询价转让股份 相关资格的核查意见 二、关于参与本次询价转让股东相关资格的核查情况 (一)核查过程 根据相关法规要求,中信证券对出让方的相关资格进行了核查。出让方已出 具《关于向特定机构投资者询价转让首次公开发行前已发行股份出让方资格相关 事宜的承诺函》。中信证券已完成出让方资格核查工作,对出让方进行访谈和问 询,并收集相关核查文件。此外,中信证券还通过公开信息渠道检索等手段对出 让方资格进行了核查。 (二)核查情况 1、南网能创股权投资基金(广州)合伙企业(有限合伙) 广东省深圳市福田区中心三路 8 号卓越时代广场(二期)北座 1 中信证券股份有限公司(以下简称"中信证券")受南方电网电力科技股份 有限公司(以下简称"南网科技")股东南网能创股权投资基金(广州)合伙企 业(有限合伙)(以下简称"出让方")委托,组织实施本次南网科技首发前股 东向特定机构投资者询价转让(以下简称"本次询价转让")。 根据《关于在上海证券交易所设立科创板并试点注册制的实施意见》《科创 板上市公司持续监管办法(试行)》《上海证券交易所科创板股票上市规则(20 ...
南网科技:股东拟询价转让1.5%公司股份
Zheng Quan Shi Bao Wang· 2026-01-09 09:15
人民财讯1月9日电,南网科技(688248)1月9日公告,南网能创股权投资基金(广州)合伙企业(有限合伙)拟 询价转让公司股份的总数为847.05万股,占南网科技总股本的比例为1.5%。本次询价转让不通过集中竞 价交易或大宗交易方式进行,不属于通过二级市场减持。受让方通过询价转让受让的股份,在受让后6 个月内不得转让。 ...
南网科技:持股5%以上股东拟询价转让1.5%股份
Xin Lang Cai Jing· 2026-01-09 09:10
Core Viewpoint - The shareholder, Nanfang Energy Creation Equity Investment Fund (Guangzhou) Partnership, plans to transfer 8.4705 million shares, representing 1.5% of the company's total equity, due to its own funding needs [1] Summary by Relevant Sections - **Share Transfer Details** - The transfer will not be conducted through centralized bidding or block trading [1] - The transferee must be an institutional investor with appropriate pricing capability and risk tolerance [1] - The minimum transfer price will not be lower than 70% of the average trading price of the company's stock over the 20 trading days prior to January 9 [1] - **Transfer Restrictions** - The transferred shares cannot be sold by the transferee within six months [1] - **Risks Associated with the Transfer** - The transfer may be suspended due to risks such as judicial freezing of shares or changes in market conditions [1]